Soluble Fas Ligand as a Potential Marker of Severity of Dengue Infection

Nurfadly Zain1, Suhartono Taat Putra2, Umar Zein3

  • 1Department of Tropical Medicine, Faculty of Medicine, Muhammadiyah University of North Sumatera, Medan, Indonesia.

Abstract

Insights

Soluble Fas ligand shows potential as an early marker for dengue infection severity. Elevated levels were observed in severe dengue haemorrhagic fever (DHF) cases compared to dengue fever (DF) and healthy controls.

Area of Science:

  • Immunology
  • Virology
  • Biochemistry

Background:

  • Microvascular endothelial cell apoptosis contributes to plasma leakage in dengue haemorrhagic fever (DHF).
  • Soluble Fas ligand (sFasL), a 40 kDa protein, mediates apoptosis and is implicated in disease pathogenesis.
  • Differentiating dengue fever (DF) from DHF early is crucial for patient management.

Purpose of the Study:

  • To investigate the potential of soluble Fas ligand as an early predictive marker for dengue infection severity.
  • To compare soluble Fas ligand levels between dengue fever (DF) and dengue haemorrhagic fever (DHF) patients.

Main Methods:

  • A prospective study involving 42 dengue patients (22 DF, 20 DHF) and 20 healthy controls.
  • Soluble Fas ligand concentrations were quantified using the enzyme-linked immunosorbent assay (ELISA).

Main Results:

  • Significantly higher soluble Fas ligand levels were found in DHF patients (median = 130.19) compared to DF patients (median = 104.73) and controls (median = 87.16).
  • The observed difference in sFasL levels was statistically significant (P < 0.001).

Conclusions:

  • Soluble Fas ligand may serve as a valuable early marker for predicting dengue infection severity.
  • Further research with larger cohorts is recommended to validate these findings.

Related Concept Videos